To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these-familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia -appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders-polygenic hypercholesterolemia and sporadic hypertriglyceridemia-each affected about 6% of survivors in both age groups.
The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and h'as been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to (5, 6) . Nonfamilial hyperlipidemias are often secondary to such factors as diet, alcohol intake, estrogen therapy, or to diseases such as diabetes mellitus, hypothyroidism, or nephrosis (3) . In some cases, neither hereditary nor identifiable environmental factors can be implicated, and such cases are referred to in this paper as sporadic hyperlipidemia.' Current laboratory tests used to define hyperlipidemia and to distinguish among the monogenic, polygenic, sporadic, and secondary disorders include measuring the plasma levels of total cholesterol, low density lipoprotein (LDL)-cholesterol, and total triglyceride (2) . However, none of these measurements directly reflects the primary action of genes as do the measurements of proteins and enzymes in such disorders as the hemoglobinopathies. Instead, they are the result of combined genetic and environmental influences.
Monogenic and polygenic causes of hyperlipidemia most likely differ in the underlying biochemical lesion and in the response to diet and drug therapy. Assessing the importance of genetic factors requires a detailed study of cholesterol and triglyceride levels in relatives of hyperlipidemic probands. In hyperlipidemia transmitted as an autosomal dominant trait, lipid levels in first-degree relatives would be composed of two distinct distributions-one reflecting the presence of normal relatives and the other that of affected relatives. This distribution of lipid values would result in a bimodal curve. Bimodality is most easily detected if the mean of the quantitative parameter under study differs significantly between normals and affected, if the spread or variance of the values is not too dissimilar in the two groups, and if the proportion of relatives in each group is nearly equal (7) . With dominant inheritance, a characteristic vertical pedigree pattern would be found in both near and distant relatives. In polygenic inheritance the quantitative parameter being studied is continuously distributed, and no distinct separation ' The term "polygenic" has been used in the broad sense to imply a multifactorial mechanism, in which observed familial variations could be determined either by multiple genetic factors, by a single genetic locus with one or many alleles interacting with environmental variation, or exclusively by environmental variation. In the strict genetic sense, a sporadic case of hyperlipidemia could be the result of a new autosomal dominant mutation, autosomal recessive inheritance, incomplete penetrance in autosomal dominant inheritance, or a nongenetic entity.
between normals and affected is evident (8, 9) . Thus, the lipid levels in relatives of individuals with polygenic hyperlipidemia would form a single distribution with a mean higher than that of controls. Affected family members are most frequently found among first-degree relatives such as sibs, parents, and children, and would be considerably less frequent in more distant relatives (8, 9) . In sporadic hyperlipidemia, lipid levels in relatives of all degrees should be identical with those of controls.
Utilizing as probands for detailed family studies the hyperlipidemic survivors of myocardial infarction identified in the accompanying paper (10) , the present investigation was undertaken with the following aims:
to delineate the different forms of familial and nonfamilial hyperlipidemia in patients with myocardial infarction, to characterize the mechanisms of inheritance of any familial disorders, and to determine their frequency.
METHODS
Selection of surviizofs as probands for family studies. Of the 500 survivors of myocardial infarction investigated in the accompanying paper (10) , 176 were selected as probands for family studies as follows: (a) An attempt was made to investigate the families of all hyperlipidemic survivors whose level of adjusted plasma cholesterol and/or triglyceride equaled or exceeded the 95th percentile value of controls. Of 157 such survivors, family studies were carried out in 131. The remaining 26 hyperlipidemic survivors had either no living first-degree relatives (13 survivors) or fewer than three available first-degree relatives (13 survivors 11, 5 had lipid values at the time of study below the 95th percentile (10) . (d) 27 normolipidemic survivors whose plasma cholesterol and triglyceride were both below the 90th percentile were also included as probands and the lipid values of their relatives were used as control family data.
Family studies. Family histories were taken and pedigrees were constructed to include every first-degree relative for each of the 500 survivors of myocardial infarction studied in the accompanying paper (10 (10) . Lipoprotein quantification and phenotyping were performed on repeat plasma samples using methods described in the accompanying paper (11) .
Control data. The levels of cholesterol and triglyceride were obtained from 950 spouse controls and adjusted for differences in age and sex as described in the accompanying paper (10 I reflected polygenic inheritance (9) . Thousands of such simulated families were computer generated. The first 60 families fulfilling the criteria of having a hyperlipidemic index case (>95th percentile) and at least 1 unequivocally hyperlipidemic relative (>99th percentile) were selected for genetic analysis. When the frequency distributions of lipid values in relatives of these artificially generated data were plotted, the curves for both cholesterol and triglyceride appeared unimodal and significantly shifted to the right of the control curve. An example of such simulated computer data for triglyceride is shown in Fig. 1 . Since these simulated family data did not give results resembling monogenic inheritance (i.e., no bimodality), it seemed reasonable to conclude that the approach used in these studies to sort families for heterogeneity did not create artifical bimodality. Analysis of data. In addition to the methods described in the accompanying paper (10), the following procedures were used in the genetic analysis. It was necessary for testing the single gene hypothesis to decompose each of the frequency distributions of lipid values of affected and normal relatives from the various family groups into two components with the most likely overlapping Gaussian distributions. Initial estimates of the parameters of the respective components were obtained by dissecting the plots of the cumulative frequency distribution on probability paper (probit analysis) by the graphical method of Harding (12 (15) . 4 Documentation of coronary heart disease in relatives. Copies of 90% of all requested death certificates were obtained for first-degree relatives over 35 yr of age. Death was attributed to myocardial infarction whenever one of the following conditions was listed as a direct cause of death: myocardial infarction, coronary occlusion, coronary atherosclerosis, coronary thrombosis, arteriosclerotic cardiovascular disease, or sudden death. Less specific terms such as organic heart failure, degenerative heart disease, congestive heart failure, and chronic myocarditis were not considered sufficiently indicative of coronary heart disease. Myocardial infarction was accepted in living relatives when their medical history form indicated hospitalization for "myocardial infarction," "coronary thrombosis," or "heart attack." 4 Although Murphy and Bolling indicated that sometimes convergence of the estimates is not possible when the variances in the two components are not equal (15) , this problem did not occur in our data, possibly as the result of the nearly precise initial estimates which greatly reduced the number of iterations (and hence the chance of encountering a point of singularity in the likelihood function) and also because we used less stringent convergence criteria. Occasionally, a small number of outliers with triglyceride values greater than 600 mg/100 ml (<2% of the total sample) severely affected the mean and standard deviation estimates in the second component. For these particular family groups three components were estimated, with the outliers contained in the last component. This proved to be a more effective way of handling the outlying values than winsoring (i.e., making all values greater than 600 mg/100 ml equal to 600), since the winsored values also affected the parameters of the second component.
RESULTS
Lipid levels in relatives of normolipidemic survivors. The mean and SD of age and sex-adjusted cholesterol and triglyceride levels in 113 adult relatives of 27 normolipidemic survivors were 215±39 and 94±54 mg/100 ml, respectively; as compared with the control values of 218±41 and 93±48. Furthermore, the frequency distributions for both cholesterol and triglyceride in these 113 normal relatives appeared unimodal and were identical with those of the controls. This excellent agreement confirmed the validity of the control values and indicated that any differences in the lipid distributions between controls and relatives of hyperlipidemic survivors could not be attributed to obtaining fasting blood samples from many relatives located in diverse geographic areas.
Lipid levels in spouse pairs. To determine whether any familial similarities in lipid levels could result from environmental similarities between family members, plasma lipids in the first 440 consecutively studied husband-wife pairs (including hyperlipidemic and normolipidemic spouses) were compared. Since no significant correlations were found for either cholesterol (r = -0.023) or triglyceride (r = +0.098), it was concluded that dietary and other environmental factors common to spouse pairs could not account for familial elevations in plasma lipids. Therefore, no corrections were necessary for nongenetic familial effects.
Lipid levels in relatives of hyperlipidemic survivors. Lipid levels in 645 adult first-degree relatives of all 149 hyperlipidemic survivors were compared with those of controls. The age and sex-adjusted values for both cholesterol and triglyceride (mean±SD) were significantly higher (P < 0.001) in relatives (235±53 and 126± 174, respectively) than in controls (218±41 and 93±48). These differences became more striking when the hyperlipidemic survivors were separated into groups: those with hypercholesterolemia with or without an associated elevation in triglyceride (n = 81) and those with hypertriglyceridemia with or without an associated elevation in cholesterol (n = 107). (36 of these survivors showed an elevation in both lipids and therefore were included in both groups.) The mean+SD value for cholesterol in the adult first-degree relatives (n = 379) of the hypercholesterolemic survivors was 247+56 mg/100 ml (control, 218±41) whereas the mean+SD value for triglyceride in the adult first-degree relatives (n = 434) of the hypertriglyceridemic survivors was 140± 200 mg/100 ml (control, 93±48). These data indicated that familial factors play an important role in the etiology of hyperlipidemia in patients with coronary heart disease. The absence of correlations in lipid levels between husbandHyperlipidemia in Coronary Heart Disease 1547 Since the variation in plasma cholesterol and/or triglyceride among relatives in Groups A-1, A-2, and A-3 was 5 to 9 times greater than that of the control families, we tested the genetic hypothesis that the hyperlipidemia in each of these three groups was determined by a different major gene.
Group A-1: familial hypercholesterolemia. The frequency distribution of adjusted lipid levels in 132 relatives of 16 hypercholesterolemic survivors (13 men, 3 women) is shown in Fig. 2 . As compared with that of controls, the distribution of cholesterol was suggestive of bimodality-the first mode corresponding to controls and containing the normal relatives and the second mode containing the affected relatives ( Fig. 2A) . More quantitative evidence for bimodality was obtained by plotting the cumulative frequency distribution on normal probability paper (Fig. 3A) . The plot of control values yielded one straight line, indicating a single Gaussian curve (12) . The plot of the relatives' values contained two straight line segments, suggesting two Gaussian curves-one for normal relatives and the other for affected relatives (12) . The break in the plot (i.e., the nonstraight line segment) reflected the apparent antimode of the two overlapping distributions; its upper limit corresponded approximately to the 90-95th percentile range of controls. Since these data suggested a mixture of two normal distributions, the best fitting two-distribution mixture was obtained by the maximum likelihood computer procedure described in the Methods. The mean+SD of 214.2+28.5 mg/100 ml for the first component was very close to that of controls (218); the mean of the second component was 299.2A58.3.5
The mean4SD for triglyceride of relatives (89.7 +t53.1 mg/100 ml) was not significantly different from that of controls (93448), and the distributions showvn in Figs. 2B and 3B were unimodal.
The pedigrees of each of the 16 families in this group are presented in Fig. 4 . Vertical transmission of hypercholesterolemia is evident from the frequent expression in offspring of affected individuals. Although hypertriglyceridemia was observed in some of these hypercholesterolemic individuals, their whole plasma ratio of cholesterol/triglyceride was almost always greater than 2, a finding not observed in individuals with other forms of familial hyperlipidemia (2, 3) . Finally, at least seven of these families had one or more affected members known to have tendinous xanthomas (viz., families 45, 120, 289, 292, 314, and 497).
In order to determine the pattern of inheritance of the hypercholesterolemia in these 16 families, segregation analyses were carried out. In the absence of a complete separation between the cholesterol distributions of normal and affected phenotypes, relatives were classified as affected or normal depending on whether or not the adjusted cholesterol level equaled or exceeded the 95th percentile of controls (285 mg/100 ml). This value closely reflected the physiologic separation between affected and unaffected relatives as determined both in this study (Figs. 2A and 3A) and in an independent study of familial monogenic hypercholesterolemia (5) . 6 Sib analysis is probably the method of choice for analyzing family lipid data of the type collected in this study. Sibs are usually of a similar age range as probands and will express a given lipid disorder which may not be apparent in children (see below). Furthermore, other methods of segregation analysis, which I The Chi-square goodness of fit was significantly better for a mixture of two overlapping distributions (P > 0.5) than for a single distribution (P < 0.025).
6The cut-off value for separating normal and affected individuals can be derived by at least four methods (reviewed by Murphy [16] ), but each of these methods gives approximately the same dividing point when the two component populations are nearly equal size, as is the case in our data. We placed the cut-off point for cholesterol at the 95th percentile of controls, so that the number of normal individuals who are misclassified as affected are minimized and the total number of affected family members is underestimated. logoTriglyceride (mg/lOOm ) FIGURE 3 Cumulative frequency distribution of adjusted lipid levels in 132 near and distant relatives of 16 survivors with familial hypercholesterolemia. The composition of the relatives group is identical with that described for Fig. 2 . The cholesterol and logie triglyceride values were age and sex-adjusted as described in the accompanying paper (10) .
consider phenotypes of living parents, are more likely to show a deficiency in the number of affected living relatives since many affected hyperlipidemic parents may have already died of myocardial infarction (17) .
The finding of an apparently bimodal distribution in the levels of cholesterol and not triglyceride in relatives, together with the results of the sib analysis showing that about one-half of living sibs were hypercholesterolemic (Table II) , are consistent with autosomal dominant inheritance. On the assumption that affected individuals die prematurely (17) , one might expect a deficiency in affected sibs. The lack of such a deficiency in our data presumably reflects the relatively young age (mean = 46 yr) of the probands and their sibs. The analysis of the proportion of affected first-and second-degree relatives (Table III) further confirmed autosomal dominant inheritance and demonstrated nearly complete expression of the hypercholesterolemia gene in affected children. The finding of a higher than expected number of affected second-degree adult relatives is probably a reflection of an ascertainment bias due to the small total number of relatives tested (n = 24) in this category.
Group A-2: familial hypertriglyceridemia. The frequency distribution of adjusted lipid levels in 132 adult relatives of 23 hypertriglyceridemic survivors (18 men, 5 women) is shown in Fig. 5 . As compared with that of controls, the distribution of triglyceride was suggestive of bimodality (Fig. SB) . When the cumulative frequencies of these data were examined on log probability paper, the plot of the relatives contained two straight line segments, indicating two Gaussian curves (Fig. 613) t Expected proportion of affected relatives on the hypothesis of autosomal dominant inheritance, assuming no effect of the gene on mortality of the ages tested and assuming no introduction of the gene by those marrying into the family. 30 second-degree relatives, and 12 thirddegree relatives. Age and sex-adjustments were carried out as described in the accompanying paper (10) . The distribution is divided into increments of 10 mg/100 ml. The smooth strippled curve represents a nonparametric density estimate of the control distribution.
affected relatives) corresponded to the 90th to 95th percentile range of controls. The best fitting twodistribution mixture, obtained by the maximum likelihood method, indicated that the mean±SD of normal relatives was 76.2±21.2, while the mean for affected relatives was 180.1+4-65. 3.7 Cholesterol levels in these same relatives were distributed as one mode that corresponded to controls (Figs. 5A and 6A). The mean±SD for cholesterol in relatives (217±36 mg/100 ml) was almost identical with that of controls (218±41).
The pedigrees of each of the 23 families in this group are presented in Fig. 7 . The inspection of these pedigrees indicates vertical transmission, but with only occasional expression of hypertriglyceridemia in children (about 12% of those at risk), and a high frequency of death by myocardial infarction in presumed carriers of the hypertriglyceridemia gene, such as parents of probands.
All these findings, as well as the results of the sib analysis (Table IV) , are consistent with an autosomal dominant mechanism of inheritance. As in familial hypercholesterolemia, no deficiency in affected sibs was noted, suggesting that any effect of the gene on mortality might be delayed until the latter part of the 5th decade of life. children as well as sibs) and second-degree relatives. The slight deficiency in the expected number of affected adult first-degree relatives (40% observed; 50% expected) was due to a deficiency in the number of affected living parents.
Group A-3: familial combined hyperlipidemia. A large number of families had affected members who expressed different combinations of elevated cholesterol and elevated triglyceride levels. Thus, affected members of the same family showed either an elevated cholesterol level with a type Ila lipoprotein pattern, an elevated triglyceride level with a type IV or type V pattern, or they showed both elevated cholesterol and triglyceride levels with a type Ilb pattern (11) . The pedigree of a large family with combined hyperlipidemia (family 41) is shown in Fig. 8 , and the lipid data for each family member in Table VI . In this family the hyperlipidemia appeared to be transmitted as a simple Mendelian autosomal dominant trait. All offspring of normals were unaffected, and on the average onehalf the offspring of affected were hyperlipidemic.
Among 157 hyperlipidemic survivors identified in the accompanying paper (10), 47 (36 men, 11 women) had pedigrees in which the combined disorder appeared to be present. Fig. 9 shows the frequency distribution of adjusted lipid levels in their 234 adult first-degree relatives. As compared with that of controls, the distribution of triglyceride was suggestive of bimodality (Fig. 9B) . The cumulative frequency when plotted on log probability paper confirmed the presence of two distributions (Fig. 10B) . The best fitting two-distribution mixture, obtained by the maximum likelihood method, indicated that the meaniSD of the normal distribution was 74.0±20.5 mg/100 ml, whereas the * Lipoprotein quantification and typing were determined by methods described in the accompanying paper (11) .
mean of the abnormal distribution was 172.3476.6 mg/ 100 mi.8 In these same relatives the distribution of cholesterol was not bimodal but appeared unimodal and shifted to the right of controls (Figs. 9A and 10A ). Its mean±SD (250±56 mg/100 ml) was significantly higher than that of the controls (2184±41) (P < 0.001). Fig. 11 indicates that this apparently unimodal curve was actually composed of two overlapping distributions -a normal cholesterol distribution in relatives whose triglyceride levels were normal (<90th percentile) and a shifted cholesterol distribution in relatives whose triglyceride levels were elevated (.90th percentile). 8 The Chi-square goodness of fit was significantly better for a mixture of two overlapping distributions (P > 0.5) than for a single distribution (P < 0.005).
The difference in mean±SD of these two distributions (238±50 and 277±E60 mg/100 ml, respectively), although highly significant (P < 0.001), was not great enough to be resolved as a bimodal curve unless the triglyceride level was used as a discriminant (Fig. 9A) . It should be noted that while the distribution and median of the cholesterol levels in the normotriglyceridemic relatives resembled those of controls (Fig. 11) , the actual mean±tSD of the cholesterol levels of the normotriglyceridemic relatives (238±50) was significantly higher than that of the controls (218±41) (P < 0.01). This higher mean value in the normotriglyceridemic relatives was due to the cholesterol values of about 6% of relatives who showed hypercholesterolemia without hypertriglyceridemia. These data suggested that familial combined hyperlipidemia survivors with familial combined hyperlipidemia. Age and sex-adjustments were carried out as described in the accompanying paper (10) . The distribution is divided into increments of 10 mg/100 ml. The smooth strippled curve represents a nonparametric density estimate of the control distribution.
is determined by a single gene whose primary action is on triglyceride metabolism with secondary effects on cholesterol metabolism. This interpretation comes from the generalization that when several phenotypic effects of a gene are considered, discrimination into distinct genetic classes becomes increasingly evident as one gets closer to the primary effect of the gene (18) . As a control, similar analyses of the cholesterol curve of the adult relatives of the familial hypertriglyceridemic disorder were done. These data indicated that although the mean cholesterol of the hypertriglyceridemic relatives (228 mg/100 ml) was slightly higher than that of the unaffected relatives (211 mg/ 100 ml) (P < 0.1, but >0.05), neither the hypertriglyceridemic nor the unaffected relatives had cho- t Expected proportion of affected relatives on the hypothesis of autosomal dominant inheritance, assuming no effect of the gene on mortality at the ages tested and assuming no introduction of the gene by those marrying into the family. § Distribution (percent) of phenotypes of affected relatives are indicated in parenthesis in the following order: hypercholesterolemia alone, hypertriglyceridemia alone, and both hypercholesterolemia and hypertriglyceridemia. (5, 19, 20) . In 20 additional matings between two normal individuals. only 2 ollt of 49 offspring (over half of which were above 20 yr of age) were hyperlipidemic.
Comparison of lipids in relatives, ages 6-20, in familial hypercholesterolemia, familial hypertriglycersidemia, and familial combined hyperlipidemia. Fig. 13 compared the distribution of unadjusted plasma lipids in first-, second-, and third-degree relatives, ages 6-20, from families with familial hypercholesterolemia (Fig. 13A ), familial hypertriglyceridemia (Fig. 13B) , and familial combined hyperlipidemia (Fig. 13C) . Unadjusted values were used in this analysis since plasma lipid levels in 110 control individuals (ages 6-20) showed no significant correlation with age (see legend to Fig.  13 and reference 21). The cholesterol distribution was bimodal in the young trelatives of probands with familial hypercholesterolemia (Fig. 13A, left) . The cholesterol curve in relatives of probands with combined hyperlipidemia was predominantly unimodal, although there was a slight suggestion of a second mode involving about 2% of the total sample (Fig. 13C, left) . The triglyceride distribution in familial hypercholesterolemia was unimodal (Fig. 13A, right) , but appeared bimodal in familial hypertriglyceridemia (Fig. 13B , right) and in familial combined hyperlipidemia (Fig.  13C, right) . These data provide further evidence that familial combined hyperlipidemia is genetically distinct from familial hypercholesterolemia and demonstrate FIGURE 13 Frequency distribution of unadjusted lipid levels in near and distant relatives, age 6-20, of 16 probands with familial hypercholesterolemia (A), 23 probands with familial hypertriglyceridemia (B), and 47 probands with familial combined hyperlipidemia (C). The number of relatives tested for each disorder is indicated in the appropriate panel. No age and sex-adjustments were applied to these data since no significant correlation with age was observed in values from 1.10 controls, ages 6-20 (see below). Moreover, when these data were reanalyzed using the age and sex-adjustments described in the accompanying paper (10) (Table I) . Since these survivors in group B consisted of a mixture of hypertriglyceridemic and hypercholesterolemic individuals, we arbitrarily divided them into two groups: those with pure hypertriglyceridemia (n = 31) and those with hypercholesterolemia with or without hypertriglyceridemia (n = 28).
The distribution of adjusted plasma lipids of 158 adult relatives of these nonfamilial pure hypertriglyceridemic survivors is shown in Fig. 14 . Both the cholesterol and triglyceride curves in relatives appeared unimodal, and the mean±SD for cholesterol (211±41 mg/100 ml) and for triglyceride (93±52 mg/100 ml) were almost identical with those of controls. Analysis of the sibs of these 31 survivors (Table X) showed that less than 2% were hypertriglyceridemic. Both lines of evidence suggest that inheritance factors do not play a direct role in the pathogenesis of hyperlipidemia in these survivors. We have therefore designated them as "sporadic" cases in the nongenetic sense.
The distribution of adjusted plasma lipids of 145 adult relatives of the hypercholesterolemic survivors CraPesier'e /lOmm!n Agrrl 1 yrer de -mg/ 100mi1 FIGURE 15 Frequency distribution of 145 near and distant adult (>20 yr of age) relatives of 28 survivors with polygenic hypercholesterolemia. Included in this analysis were 119 first-degree, 20 second-degree, and 6 third-degree relatives. Age and sex-adjustments were carried out as described in the accompanying paper (10) . The distribution is divided into increments of 10 mg/100 ml. The smooth strippled curve represents a nonparametric density estimate of the control distribution.
in group B is shown in Fig. 15 . The triglyceride curve corresponds to that of controls, while the cholesterol curve is unirnodal with a higher mean than that of controls and was shifted to higher values (Fig. 15A) . Such a unimodal, displaced curve in relatives of probands is compatible with the hypothesis that multiple cholesterol-elevating genes-possibly in conjunction with environniental factors-are operative in such relatives. \Whereas a multifactorial or polygenic mechanism is most likely, such a curve can also be caused entirely by environmental variations, or may be generated by the action of a single genetic locus with one or many alleles. Table XI indicated that about 7SO of sibs were hypercholesterolemic by the arbitrary criteria used. This interpretation of multifactorial inheritance of hypercholesterolemia is further substantiated by the finding of significant correlations in cholesterol levels of parent-child (r = +0.200) and sib-sib (r = +0.354) pairs among normolipidemic families. Such correlations, in the absence of similar husband-wife correlations (r = -0.023), fit the concept that one of several mechanisms produce hypercholesterolemia: polygenic. monogenic, and nongenetic.
Summary of genetic analysis of hyperlipidemic survivors of myocardial infarction. A summary of our genetic analysis is presented in Fig. 16 . Of the 157 hyperlipidemic survivors of myocardial infarction identified in the accompanying paper (10), 15% could not be classified because of lack of available living relatives (see Methods). 54% had one of the three monogenic disorders, the most frequent being familial combined hyperlipidemia which was observed in about one-third of all hyperlipidemic survivors. Except for four survivors with type III hyperlipidemia (see the accompanying paper [1E]), the remaining 31% of hyperlipidemic survivors had either a polygenic or sporadic form of hyperlipidemia.
Frequency of hyperlipidemia in survivors of myocardial infarction and in the general population. Since our study involved virtually all survivors of myocardial infarction under age 60 and a randomly selected group age 60 and above who were admitted to most of the hospitals in a metropolitan area during a period of 11 mo, it was possible to estimate the overall frequencies of the various disorders identified in this study. These data are shown in Table XII . In extrapolating from our observed data in survivors under age 60 to findings in the general population, it was necessary to make several assumptions each of which tended to underestimate the heterozygote frequency of these disorders. (These assumptions are enumerated in the legend of Table XII.) Although the monogenic disorders were about three times more common in the younger (< age 60) survivors than in the older survivors, both polygenic hypercholesterolemia and sporadic hypertriglyceridemia appeared equally common (each with a frequency of about 6%) among young and old survivors. Familial hypercholesterolemia occurred in 4.1% of all consecutively studied survivors under age 60 and in 0.7% of the group of randomly studied older survivors. A rough estimate of its frequency in the general population is 0.1-0.2%. Familial hypertriglyceridemia was slightly more common, occurring in 5.2% of survivors under age 60 and 2.7% of the older group.
Its population frequency is estimated at 0.2-0.3%. Familial combined hyperlipidemia occurred in 11.3% of all survivors under 60 and 4.1% of the older survivors. Its population frequency is estimated at FIGURE 16 Summary of genetic analysis in 157 hyperlipidemic survivors of myocardial infarction. The unclassified category represents those hyperlipidemic survivors in whom family study was not possible because of lack of availability of at least three relatives. Type III hyperlipidemia (not included here) was identified in four, or 2.4%, of these 157 hyperlipidemic survivors (11) . (19) . Moreover, we have recently investigated a large kindred (not part of this study) consisting of 74 members in whom elevated levels of triglyceride but not of cholesterol segregated as an autosomal dominant trait throughout the first-, second-, third-, and fourth-degree relatives of the proband (unpublished observations).
Familial combined hyperlipidemia. The most interesting finding in this study was the delineation of a newly recognized lipid disorder-familial combined hyperlipidemia. It was characterized by variability in expression of lipid levels among affected relatives such that any combination of elevation in LDL cholesterol and very low density lipoprotein (VLDL) triglyceride or both were observed among affected relatives. As described in the accompanying paper (11) , affected individuals with this disorder manifested any one of four lipoprotein phenotypes: type Ila, type IIb, type IV, or type V patterns. In the individual family with combined hyperlipidemia, the pedigree was often puzzling and confusing because of this variability in phenotypes. But, when the family data were extensive enough and lipid levels were measured in children, the disorder was relatively easy to distinguish from both familial hypercholesterolemia and familial hypertriglyceridemia.
Several lines of genetic evidence indicate that combined hyperlipidemia is genetically distinct from both familial hypercholesterolemia and familial hypertriglyceridemia. First, the pattern of lipid distributions in relatives, showing an apparently bimodal triglyceride curve and a unimodal and shifted cholesterol curve, was unique. Second, the observation that the hypertriglyceridemic relatives with the combined disorder had abnormally elevated levels of cholesterol was not observed in the familial hypertriglyceridemic disorder in which the hypertriglyceridemic relatives had normal levels of cholesterol. Third, in contrast to the findings of familial hypercholesterolemia, elevation in cholesterol alone was not observed in children of adults affected with combined hyperlipidemia. Fourth, in families with this disorder, a hypercholesterolemic X normal mating frequently gave rise to hypertriglyceridemic progeny; conversely, hypertriglyceridemic X normal matings often produced hypercholesterolemic progeny. These observations were consistent with variable expression of a single autosomal dominant gene. It remains to be seen whether all of the 47 families with combined hyperlipidemia actually have the same abnormal gene, since biochemical and genetic heterogeneity cannot be ruled out by the present studies.
Since the earliest manifestation in affected children with combined hyperlipidemia was hypertriglyceridemia alone, the primary biochemical abnormality in this disorder may involve triglyceride metabolism with secondary effects on cholesterol metabolism. Additional evidence supporting this hypothesis is the fact that triglyceride levels in relatives appeared to segregate into two distributions, whereas their cholesterol levels showed a less clear-cut bimodality. Furthermore, the recent demonstration that plasma LDL may arise physiologically from the catabolism of VLDL (22, 23) documents an interrelationship of these two lipoprotein classes and hence of plasma cholesterol and triglyceride, suggesting a possible metabolic site for the lesion in combined hyperlipidemia. In this respect, our postulation that the primary defect in combined hyperlipidemia involves triglyceride transport provides a reasonable explanation for the occurrence of either hypertriglyceridemia alone or both hypertriglyceridemia and hypercholesterolemia in affected individuals. However, the finding of hypercholesterolemia alone in a minority of affected individuals with the combined disorder cannot readily be explained by this hypothesis. Its occurrence therefore provides a challenge for additional work on the pathos physiology and biochemistry of lipoprotein metabolism.
In their recent study of lipid abnormalities in survivors of myocardial infarction, Patterson and Slack did not detect familial combined hyperlipidemia (24) . However, only 39 first-degree relatives from families with all types of familial hyperlipidemia were tested, precluding the possibility of picking out this disorder. However, these authors did observe hypertriglyceridemia in relatives of probands with hypercholesterolemia and vice versa.
In keeping with our identification of combined hyperlipidemia as a genetic entity is the recent report of Rose, Kranz, Weinstock, Juliano, and Haft (25) . These authors independently concluded that combined hyperlipidemia was different from either familial hypercholesterolemia or familial hypertriglyceridemia. Furthermore, one report in 1968 by Matthews of a kindred in which hypercholesterolemia and hypertriglyceridemia Hyperlipidemia in Coronary Heart Disease occurring as different phenotypic expressions of the same mutant gene (26) and another report in 1969 by Schreibman, Wilson, and Arky of a family with familial type IV hyperlipidemia (27) were both, in retrospect, probable examples of familial combined hyperlipidemia.9 Although widely quoted as an example of familial type IV hypertriglyceridemia (and originally designated as such because of the presence in affected family members of a pre-beta band on lipoprotein electrophoresis of whole plasma), the kindred studied by Schreibman et al. (27) actually contained among the eight affected relatives two with hypercholesterolemia alone, one with hypertriglyceridemia alone, and five with both hypercholesterolemia and hypertriglyceridemia. Like the large pedigree shown in Fig. 10 (28, 29) rather than the observed 45-55 and 20-30%. With lower heritabilities, these estimates for the proportion of affected first-and second-degree relatives under a polygenic model would be even less (28, 29) .10 Furthermore, whereas the ratio of hyperlipidemic probands having a myocardial infarction was 4: 1 (male: female), no deviation from unity in the sex ratio among hyperlipidemic relatives was noted-another argument favoring monogenic inheritance (30) . Finally, in contrast to some other polygenically determined disorders where a higher proportion of relatives is affected if the proband is severely affected (28) , no such phenomenon was observed in our data. For example, probands whose lipid levels fell in the 95-98th percentile range had as many relatives affected with lipid levels in the 99th percentile as did probands whose lipid levels fell in the 99th percentile (unpublished observations).
Although the above considerations seem most consistent with single gene inheritance, the evidence for major gene effects on quantitative traits such as cholesterol and triglyceride cannot be considered incontrovertible until a specific biochemical defect for each of the three disorders is identified. Alternatively, the discovery of chromosomal linkage to a known marker 10 In studies carried out with Dr. Joseph Felsenstein, the heritability and the components of the total phenotypic variance for both the levels of cholesterol and triglyceride in these monogenic families were estimated by a maximum likelihood computer program. Covariance information between relatives was computed using all degrees of relationship, including near and distant relatives and spouses. The phenotypic variance was partitioned into the following components: additive variance, Va; dominance variance, Vd; and environmental or nongenetic variance, Ve (9) . In this type of analysis, the heritability (i.e., the genetic contribution to the total variance) is defined in the broad sense as, Va (31) . Until detailed studies are performed on the families of hyperlipidemic individuals selected at random from the general population, the heterozygote frequencies reported here should be considered only as approximate. Assuming, however, that our estimates are correct and that no more than 1 % of the general population carries a gene for one of the monogenic forms of hyperlipidemia, it is predictable that the polygenic and sporadic form of hyperlipidemia affecting 4% of the population will turn out to be the most common forms of these disorders in individuals without coronary heart disease. It should be pointed out, however, that the diagnosis of a polygenic disorder depends on quantitative, rather than qualitative data, requiring arbitrary cut-off values. Therefore, making a distinction between normal and affected individuals can be difficult. On the other hand, for a monogenic disorder a clear qualitative difference is ultimately obtainable and the individual diagnosis can be made more confidently.
If the data of this study can be confirmed and if familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia can in fact each be proven to be determined by a separate major gene, then these genes affecting lipid metabolism and ultimately the pathogenesis of coronary heart disease are among the most common disease-producing genes in our population. Considering that at least 1 in 160 individuals may carry one of these three genes, the familial hyperlipidemic disorders are major public health problems.
It is tempting to speculate that one reason for the rising frequency of premature coronary heart disease in affluent societies may be the interaction between a genetic factor such as one of these hyperlipidemic genes whose frequency has presumably not changed over many generations and some newly introduced environmental factor(s) such as diet, stress, and/or sedentary habits. Such a mechanism would be analogous to other types of heredity-environment interaction (32) and implies that different approaches may be required in preventing the various hyperlipidemic disorders. The existence of distinct monogenic hyperlipidemias offers defined subpopulations for assessing the effects of various drugs and diets and also emphasizes the need for a vigorous search to identify the underlying metabolic defect and biochemical lesion in each disorder.
Note added in proof. E. A. Nikkila and A. Aro (1973.
Lancet. 1: 954.) have independently reported that the most common form of familial hyperlipidemia in survivors of myocardial infarction is one in which multiple lipoprotein types are observed among about 50% of the first-degree relatives. These observations are similiar to our data on the familial combined hyperlipidemia disorder.
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